Cell & Gene Therapy Bioprocessing & Commercialization is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Austin Thiel
Senior Principal Scientist at Semma Therapeutics, USA

Profile

Austin is Director of Cell Therapy Development at Semma Therapeutics, where he is focused on developing a pluripotent stem cell-derived pancreatic islet therapy for type 1 diabetes. Austin has a B.S. from Penn State University and a Ph.D. in Cell and Molecular Biology from the University of Pennsylvania. He has several years of experience developing stem cell-derived therapies. Austin previously worked at ACT/Ocata Therapeutics prior to joining Semma in early 2016.

Austin Thiel's Network

Agenda Sessions

  • Semma Therapeutics – Developing a scaled process for manufacturing stem cell derived islets

    ,
  • Next generation therapies

    ,